Business Description
Diagnamed Holdings Corp
NAICS : 541519
SIC : 8629
ISIN : CA25245D1033
Description
Diagnamed Holdings Corp is engaged in developing a platform of software-based prescription digital therapeutic products (PDT Products) with the potential to improve early detection of neurological disorders, overall patient health and lower healthcare costs. Its products include, CERVAI which is a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders. It is also investigating other technological applications such as BrainAge and BrainTremor.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.5 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 59.93 | |||||
| 9-Day RSI | 55.01 | |||||
| 14-Day RSI | 52.5 | |||||
| 6-1 Month Momentum % | 28.57 | |||||
| 12-1 Month Momentum % | -30.77 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2 | |||||
| Quick Ratio | 2 | |||||
| Cash Ratio | 1.69 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 11.67 | |||||
| EV-to-EBIT | -2.6 | |||||
| EV-to-EBITDA | -2.6 | |||||
| EV-to-FCF | -2.98 | |||||
| Earnings Yield (Greenblatt) % | -38.47 | |||||
| FCF Yield % | -24.52 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Diagnamed Holdings Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | |||
| EPS (TTM) (C$) | -0.022 | ||
| Beta | 0 | ||
| Volatility % | 80.2 | ||
| 14-Day RSI | 52.5 | ||
| 14-Day ATR (C$) | 0.004862 | ||
| 20-Day SMA (C$) | 0.0375 | ||
| 12-1 Month Momentum % | -30.77 | ||
| 52-Week Range (C$) | 0.02 - 0.1 | ||
| Shares Outstanding (Mil) | 80.05 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Diagnamed Holdings Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Diagnamed Holdings Corp Stock Events
| Event | Date | Price(C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Diagnamed Holdings Corp Frequently Asked Questions
What is Diagnamed Holdings Corp(XCNQ:DMED)'s stock price today?
The current price of XCNQ:DMED is C$0.04. The 52 week high of XCNQ:DMED is C$0.10 and 52 week low is C$0.02.
When is next earnings date of Diagnamed Holdings Corp(XCNQ:DMED)?
The next earnings date of Diagnamed Holdings Corp(XCNQ:DMED) is .
Does Diagnamed Holdings Corp(XCNQ:DMED) pay dividends? If so, how much?
Diagnamed Holdings Corp(XCNQ:DMED) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers